Metformin
Diabetes Prevention in Women After GDM Who Are at High-risk
Woman'sSmall moleculePhase 3Dormant
BB
67/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 53/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Diabetes Prevention in Women After GDM Who Are at High-risk cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Metformin Ain Shams University | Phase 4 | A |
Liraglutide Woman's | Phase 3 | BB |
Dapagliflozin Woman's | Phase 3 | BB |
ADIPOQ University of Minnesota | D | |
TNF-.ALPHA. University of Minnesota | D | |
Folic Acid University of Messina | N/A | D |
Same molecule, other indications
Metformin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →